Khan D, Kirby D, Bryson S, Shah M, Rahman Mohammed A. Paediatric specific dosage forms: patient and formulation considerations. Int J Pharm. 2022;616:121501.
Article CAS PubMed Google Scholar
Solans-Domènech M, Saborit S, coordinators and Hypatia of Alexandria Charter Group. Incorporating the sex and gender perspective in research content: a toolkit. Barcelona (Spain): agency for health quality and assessment of Catalonia (AQuAS). Catalan Health Ministry. Government of Catalonia; 2022.
Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, et al. Preparation of medicines for children - a hierarchy of classification. Int J Pharm. 2012;435(2):124–30.
Article CAS PubMed Google Scholar
Litalien C, Bérubé S, Tuleu C, Gilpin A, Landry ÉK, Valentin M, et al. From paediatric formulations development to access: advances made and remaining challenges. Br J Clin Pharmacol. 2022;88(10):4349–83.
Watts G. WHO launches campaign to make drugs safer for children. BMJ (Clinical Res ed). 2007;335(7632):1227.
Lehmann B. Regulation (EC) 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations. Child Adolesc Psychiatry Mental Health. 2008;2(1):37.
Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871–89.
Article CAS PubMed PubMed Central Google Scholar
EMA. Guideline on pharmaceutical development of medicines for paediatric use. Europe2012. pp. 1–24.
Mason J, Pirmohamed M, Nunn T. Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature. Eur J Clin Pharmacol. 2012;68(1):21–8.
Ley 29. /2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios., 29/2006. Sect. Titulo II, capitulo I (2006).
Brion F, Nunn A, Rieutord AJA. Extemporaneous (magistral) Preparation of oral medicines for children in European hospitals. Acta Paediatr. 2003;92(4):486–90.
Article CAS PubMed Google Scholar
Sellers S, Utian WH. Pharmacy compounding primer for physicians. Drugs. 2012;72(16):2043–50.
Article PubMed PubMed Central Google Scholar
Watson CJ, Whitledge JD, Siani AM, Burns MM. Pharmaceutical compounding: a history, regulatory overview, and systematic review of compounding errors. J Med Toxicol. 2021;17(2):197–217.
Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1–8.
Article PubMed PubMed Central Google Scholar
Baguley D, Lim E, Bevan A, Pallet A, Faust SN. Prescribing for children - taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–7.
Mu Y, Zhao L, Shen L. Medication adherence and pharmaceutical design strategies for pediatric patients: an overview. Drug Discovery Today. 2023;28(11):103766.
Article CAS PubMed Google Scholar
National Health Service (NHS) in England, Vol. 2023, 2016.
Menditto E, Orlando V, De Rosa G, Minghetti P, Musazzi UM, Cahir C et al. Patient centric pharmaceutical drug product Design-The impact on medication adherence. Pharmaceutics. 2020;12(1).
Seoane-Viaño I, Trenfield SJ, Basit AW, Goyanes A. Translating 3D printed pharmaceuticals: from hype to real-world clinical applications. Adv Drug Deliv Rev. 2021;174:553–75.
Lafeber I, Tichem JM, Ouwerkerk N, van Unen AD, van Uitert JJD, Bijleveld-Olierook HCM, et al. 3D printed Furosemide and sildenafil tablets: innovative production and quality control. Int J Pharm. 2021;603:120694.
Article CAS PubMed Google Scholar
Li Q, Guan X, Cui M, Zhu Z, Chen K, Wen H, et al. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing. Int J Pharm. 2018;535(1–2):325–32.
Article CAS PubMed Google Scholar
Cheng Y, Qin H, Acevedo NC, Jiang X, Shi X. 3D printing of extended-release tablets of Theophylline using hydroxypropyl Methylcellulose (HPMC) hydrogels. Int J Pharm. 2020;591:119983.
Article CAS PubMed Google Scholar
Zhu C, Tian Y, Zhang E, Gao X, Zhang H, Liu N, et al. Semisolid extrusion 3D printing of propranolol hydrochloride gummy chewable tablets: an innovative approach to prepare personalized medicine for pediatrics. AAPS PharmSciTech. 2022;23(5):166.
Article CAS PubMed Google Scholar
Han X, Kang D, Liu B, Zhang H, Wang Z, Gao X, et al. Feasibility of developing hospital Preparation by semisolid extrusion 3D printing: personalized amlodipine besylate chewable tablets. Pharm Dev Technol. 2022;27(2):164–74.
Article CAS PubMed Google Scholar
Herrada-Manchón H, Rodríguez-González D, Alejandro Fernández M, Suñé-Pou M, Pérez-Lozano P, García-Montoya E, et al. 3D printed gummies: personalized drug dosage in a safe and appealing way. Int J Pharm. 2020;587:119687.
Eduardo DT, Ana SE, José BF. A micro-extrusion 3D printing platform for fabrication of orodispersible printlets for pediatric use. Int J Pharm. 2021;605:120854.
Article CAS PubMed Google Scholar
Sjöholm E, Sandler N. Additive manufacturing of personalized orodispersible warfarin films. Int J Pharm. 2019;564:117–23.
Boniatti J, Januskaite P, Fonseca LBd, Viçosa AL, Amendoeira FC, Tuleu C et al. Direct powder extrusion 3D printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations. 2021;13(8):1114.
Hu J, Fitaihi R, Abukhamees S, Abdelhakim HE. Formulation and characterisation of carbamazepine orodispersible 3D-Printed Mini-Tablets for paediatric use. Pharmaceutics. 2023;15(1).
Goh WJ, Tan SX, Pastorin G, Ho PCL, Hu J, Lim SH. 3D printing of four-in-one oral polypill with multiple release profiles for personalized delivery of caffeine and vitamin B analogues. Int J Pharm. 2021;598:120360.
Article CAS PubMed Google Scholar
Robles-Martinez P, Xu X, Trenfield SJ, Awad A, Goyanes A, Telford R et al. 3D printing of a Multi-Layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics. 2019;11(6).
Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Controlled Release: Official J Controlled Release Soc. 2015;217:308–14.
Derossi A, Caporizzi R, Azzollini D, Severini C. Application of 3D printing for customized food. A case on the development of a fruit-based snack for children. J Food Eng. 2017;220.
Zhang C, Wang C-S, Girard M, Therriault D, Heuzey M-C. 3D printed protein/polysaccharide food simulant for dysphagia diet: impact of cellulose nanocrystals. Food Hydrocolloids. 2024;148:109455.
Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: opportunities and challenges. Pharm Res. 2016;33(8):1817–32.
Article CAS PubMed Google Scholar
Awad A, Trenfield SJ, Gaisford S, Basit AW. 3D printed medicines: A new branch of digital healthcare. Int J Pharm. 2018;548(1):586–96.
Article CAS PubMed Google Scholar
Awad A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. Reshaping drug development using 3D printing. Drug Discovery Today. 2018;23(8):1547–55.
Article CAS PubMed Google Scholar
Xue A, Li W, Tian W, Zheng M, Shen L, Hong Y. A bibliometric analysis of 3D printing in personalized medicine research from 2012 to 2022. Pharmaceuticals. 2023;16:1521.
Article PubMed PubMed Central Google Scholar
Lyousoufi M, Lafeber I, Kweekel D, de Winter BCM, Swen JJ, Le Brun PPH, et al. Development and bioequivalence of 3D-Printed medication at the Point-of-Care: bridging the gap toward personalized medicine. Clin Pharmacol Ther. 2023;113(5):1125–31.
Article CAS PubMed Google Scholar
Seoane-Viaño I, Pérez-Ramos T, Liu J, Januskaite P, Guerra-Baamonde E, González-Ramírez J, et al. Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data. J Controlled Release: Official J Controlled Release Soc. 2024;365:348–57.
Comments (0)